Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • January 2018
  • Article
  • Clinical Pharmacology & Therapeutics

Innovation Incentives and Biomarkers

By: Ariel Dora Stern, Brian M. Alexander and Amitabh Chandra
  • Format:Print
  • | Pages:3
ShareBar

Abstract

Previously, we have discussed the importance of economic incentives in shaping markets for precision medicines. Here we consider incentives for biomarker development, including discovery and establishment. Biomarkers can reveal valuable information regarding diagnosis and prognosis, predict treatment efficacy or toxicity, serve as markers of disease progression, and serve as auxiliary endpoints for clinical trials. Some have multiple uses, while others have a specialized role, resulting in diverse incentives across players in the healthcare system.

Keywords

Health Care and Treatment; Innovation and Invention; Research and Development; Markets

Citation

Stern, Ariel Dora, Brian M. Alexander, and Amitabh Chandra. "Innovation Incentives and Biomarkers." Clinical Pharmacology & Therapeutics 103, no. 1 (January 2018): 34–36.
  • Find it at Harvard
  • Purchase

About The Authors

Ariel D. Stern

Technology and Operations Management
→More Publications

Amitabh Chandra

Technology and Operations Management
→More Publications

More from the Authors

    • July 2023
    • Faculty Research

    Hello Heart: The Next Generation of Chronic Disease Management Apps

    By: Ariel Dora Stern and Kumba Sennaar
    • July 2023
    • Faculty Research

    Biogen and the Aduhelm Melee

    By: Amitabh Chandra and Lauren Gunasti
    • 2023
    • JMIR Formative Research

    Building the Business Case for an Inclusive Approach to Digital Health Measurement with a Web App (Market Opportunity Calculator): Instrument Development Study

    By: Mitchell Tang, Yashoda Sharma, Jennifer C. Goldsack and Ariel Dora Stern
More from the Authors
  • Hello Heart: The Next Generation of Chronic Disease Management Apps By: Ariel Dora Stern and Kumba Sennaar
  • Biogen and the Aduhelm Melee By: Amitabh Chandra and Lauren Gunasti
  • Building the Business Case for an Inclusive Approach to Digital Health Measurement with a Web App (Market Opportunity Calculator): Instrument Development Study By: Mitchell Tang, Yashoda Sharma, Jennifer C. Goldsack and Ariel Dora Stern
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College